Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 18.37 -0.57 (-3.01%) Market Cap: 1.25 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Phathom Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 03:00PM GMT
Release Date Price: $32.89 (-2.14%)
Rahul Sood;Morgan Stanley;Executive Director

Good morning, everyone. This is Rahul Sood here from Morgan Stanley's Healthcare Investment Banking Group.

Today, I'm joined by the management team from Phathom Pharmaceuticals. Before we get to introductions, I would like to read a quick disclosure. For important disclosures, please see the Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, it is my pleasure to introduce the management team from Phathom Pharmaceuticals. We are privileged to be joined by Terrie Curran, President and Chief Executive Officer; Azmi Nabulsi, Chief Operating Officer; and Martin Gilligan, Chief Commercial Officer.

With that, Terrie, why don't I turn it over to you?

Terrie J. Curran
Phathom Pharmaceuticals, Inc. - President, CEO & Director

Thanks, Rahul.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot